Literature DB >> 23407554

Optimal detection of ALK rearranged lung adenocarcinomas.

Niki Karachaliou, Rafael Rosell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23407554     DOI： 10.1097/JTO.0b013e318282ddc3

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

Review 1.  Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements.

Authors:  Cristina Teixidó; Niki Karachaliou; Vicente Peg; Ana Gimenez-Capitan; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2014-04

Review 2.  Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.

Authors:  Puey Ling Chia; Paul Mitchell; Alexander Dobrovic; Thomas John
Journal:  Clin Epidemiol       Date:  2014-11-20       Impact factor: 4.790

Review 3.  Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice.

Authors:  Antonio Passaro; Chiara Lazzari; Niki Karachaliou; Gianluca Spitaleri; Alessia Pochesci; Chiara Catania; Rafael Rosell; Filippo de Marinis
Journal:  Onco Targets Ther       Date:  2016-10-17       Impact factor: 4.147

Review 4.  ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-08-12       Impact factor: 6.639

5.  Diagnostic accuracy of PCR for detecting ALK gene rearrangement in NSCLC patients: A systematic review and meta-analysis.

Authors:  Xia Zhang; Jian-Guo Zhou; Hua-Lian Wu; Hu Ma; Zhi-Xia Jiang
Journal:  Oncotarget       Date:  2017-05-17

6.  Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry.

Authors:  Esther Conde; Ana Suárez-Gauthier; Amparo Benito; Pilar Garrido; Rosario García-Campelo; Michele Biscuola; Luis Paz-Ares; David Hardisson; Javier de Castro; M Carmen Camacho; Delvys Rodriguez-Abreu; Ihab Abdulkader; Josep Ramirez; Noemí Reguart; Marta Salido; Lara Pijuán; Edurne Arriola; Julián Sanz; Victoria Folgueras; Noemí Villanueva; Javier Gómez-Román; Manuel Hidalgo; Fernando López-Ríos
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

7.  Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements.

Authors:  Yoon Jin Cha; Jae Seok Lee; Hye Ryun Kim; Sun Min Lim; Byoung Chul Cho; Chang Young Lee; Hyo Sup Shim
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

8.  Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer.

Authors:  Elisa Dama; Micol Tillhon; Giovanni Bertalot; Francesca de Santis; Flavia Troglio; Simona Pessina; Antonio Passaro; Salvatore Pece; Filippo de Marinis; Patrizia Dell'Orto; Giuseppe Viale; Lorenzo Spaggiari; Pier Paolo Di Fiore; Fabrizio Bianchi; Massimo Barberis; Manuela Vecchi
Journal:  Oncotarget       Date:  2016-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.